The Royal Marsden NHS Foundation Trust, often referred to simply as The Royal Marsden, is a leading cancer treatment and research institution headquartered in Greater London, GB. Established in 1851, it has been at the forefront of cancer care for over 170 years, pioneering innovative treatments and therapies that set benchmarks in the industry. The Trust operates major facilities in Chelsea and Sutton, providing comprehensive cancer services, including diagnosis, treatment, and support for patients. Renowned for its cutting-edge research and clinical trials, The Royal Marsden is a key player in the oncology sector, consistently recognised for its contributions to cancer care and patient outcomes. Its unique integration of clinical services with research ensures that patients benefit from the latest advancements in cancer treatment, solidifying its position as a leader in the field.
How does The Royal Marsden NHS Foundation Trust's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
The Royal Marsden NHS Foundation Trust's score of 18 is lower than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
The Royal Marsden NHS Foundation Trust, headquartered in Great Britain, currently does not have available carbon emissions data for the most recent year, as indicated by the absence of specific figures. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. As of now, the Trust does not inherit emissions data from any parent organization, nor does it participate in any cascading initiatives related to climate commitments. This lack of data and targets suggests that the Trust may still be in the early stages of formalising its climate strategy and emissions reporting. In the context of the healthcare sector, it is increasingly important for organisations like The Royal Marsden to establish clear carbon reduction goals and transparent reporting practices to align with industry standards and contribute to broader climate action efforts.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
The Royal Marsden NHS Foundation Trust is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.